Zydus Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences has informed the stock exchanges that its trading window will remain closed starting April 1, 2026, until 48 hours after the company declares its audited financial results for the fourth quarter and full financial year ending March 31, 2026. During this period, directors, designated employees, and their immediate relatives cannot trade in the company's shares. This is a routine compliance step under SEBI's insider trading rules, typically taken just before announcing quarterly or annual results. The exact date of the board meeting to approve these results has not yet been disclosed and will be communicated later.
This is a standard regulatory filing and does not directly impact shareholders. However, the upcoming closure signals that Zydus' Q4 and FY2026 audited results will be announced in the coming weeks, which could be a key event for investors to watch.